Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.
Charpentier C, Lambert-Niclot S, Alteri C, Storto A, Flandre P, Svicher V, Perno CF, Brun-Vézinet F, Calvez V, Marcelin AG, Ceccherini-Silberstein F, Descamps D. Charpentier C, et al. Among authors: alteri c. PLoS One. 2013;8(1):e54381. doi: 10.1371/journal.pone.0054381. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349869 Free PMC article.
Quantitative SARS-CoV-2 subgenomic RNA as a surrogate marker for viral infectivity: Comparison between culture isolation and direct sgRNA quantification.
Scutari R, Renica S, Cento V, Nava A, Sammartino JC, Ferrari A, Pani A, Merli M, Fanti D, Vismara C, Scaglione F, Puoti M, Bandera A, Gori A, Piralla A, Baldanti F, Perno CF, Alteri C. Scutari R, et al. Among authors: alteri c. PLoS One. 2023 Sep 1;18(9):e0291120. doi: 10.1371/journal.pone.0291120. eCollection 2023. PLoS One. 2023. PMID: 37656746 Free PMC article.
A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia.
Scutari R, Fox V, De Ioris MA, Fini V, Granaglia A, Costabile V, Colagrossi L, Russo C, Mastronuzzi A, Locatelli F, Perno CF, Alteri C. Scutari R, et al. Among authors: alteri c. BMC Infect Dis. 2023 Mar 7;23(1):133. doi: 10.1186/s12879-023-08111-4. BMC Infect Dis. 2023. PMID: 36882724 Free PMC article.
Performance evaluation of a new on-demand molecular test for the rapid identification of severe acute respiratory syndrome coronavirus 2 in pediatric and adult patients.
Colagrossi L, Costabile V, Scutari R, Cento V, Coltella L, Reale A, Scilipoti M, Villani A, Alteri C, Perno CF, Russo C. Colagrossi L, et al. Among authors: alteri c. Front Microbiol. 2022 Nov 3;13:999783. doi: 10.3389/fmicb.2022.999783. eCollection 2022. Front Microbiol. 2022. PMID: 36406396 Free PMC article.
Preventing future pandemics and epidemics through a North-South collaboration on genomic surveillance in Africa.
Colizzi V, Alteri C, D'Amelio S, Garba IH, Giovanetti M, Komurian-Pradel F, Lourenço J, Mazeri S, Muwonge A, Perno CF, Russo G, Mukadi-Bamuleka D. Colizzi V, et al. Among authors: alteri c. J Public Health Afr. 2022 Sep 23;13(3):2319. doi: 10.4081/jphia.2022.2319. eCollection 2022 Sep 7. J Public Health Afr. 2022. PMID: 36277947 Free PMC article. No abstract available.
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients.
Alteri C, Fox V, Scutari R, Burastero GJ, Volpi S, Faltoni M, Fini V, Granaglia A, Esperti S, Gallerani A, Costabile V, Fontana B, Franceschini E, Meschiari M, Campana A, Bernardi S, Villani A, Bernaschi P, Russo C, Guaraldi G, Mussini C, Perno CF. Alteri C, et al. Commun Biol. 2022 Dec 15;5(1):1376. doi: 10.1038/s42003-022-04322-8. Commun Biol. 2022. PMID: 36522489 Free PMC article.
Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy.
Giuliani M, Montieri S, Palamara G, Latini A, Alteri C, Perno CF, Santoro MM, Rezza G, Ciccozzi M. Giuliani M, et al. Among authors: alteri c. AIDS Res Hum Retroviruses. 2009 Feb;25(2):157-64. doi: 10.1089/aid.2008.0175. AIDS Res Hum Retroviruses. 2009. PMID: 19108689
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.
Svicher V, Alteri C, D'Arrigo R, Laganà A, Trignetti M, Lo Caputo S, Callegaro AP, Maggiolo F, Mazzotta F, Ferro A, Dimonte S, Aquaro S, di Perri G, Bonora S, Tommasi C, Trotta MP, Narciso P, Antinori A, Perno CF, Ceccherini-Silberstein F. Svicher V, et al. Among authors: alteri c. Antimicrob Agents Chemother. 2009 Jul;53(7):2816-23. doi: 10.1128/AAC.01067-08. Epub 2009 Jan 5. Antimicrob Agents Chemother. 2009. PMID: 19124665 Free PMC article.
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.
Alteri C, Svicher V, Gori C, D'Arrigo R, Ciccozzi M, Ceccherini-Silberstein F, Selleri M, Bardacci SA, Giuliani M, Elia P, Scognamiglio P, Balzano R, Orchi N, Girardi E, Perno CF; SENDIH Study Group. Alteri C, et al. BMC Infect Dis. 2009 Jul 16;9:111. doi: 10.1186/1471-2334-9-111. BMC Infect Dis. 2009. PMID: 19607681 Free PMC article.
139 results